Limited Coverage Drugs - Quinagolide

Generic Name

quinagolide

Strength

0.075 mg, 0.150 mg
Form tablet
Criteria Approval Period

Diagnosis of hyperprolactinemia

PLUS

Treatment failure or intolerance to bromocriptine

First approval: One year

Renewals: One year

Practitioner Exemptions

  • No practitioner exemptions

Special Notes